Roth Capital Reaffirms Aduro Biotech (ADRO) at 'Buy'; Says Partial Clinical Hold Lift No Surprise Nov 21, 2016 10:01AM
Streetinsider.com's Hot Lunchtime Reads 10/24: (ADRO) (AMTD) (TWTR) (INO) Oct 24, 2016 12:15PM
Roth Capital Trims PT on Aduro Biotech (ADRO) to $20 Amid FDA Partial Hold on LADD Trials Oct 24, 2016 11:46AM
Roth Positive on Aduro Biotech (ADRO) Following Management Meetings; Depth of Pipeline Key Factor Jul 8, 2016 08:59AM
Roth Cuts PT on Aduro Biotech (ADRO) to $22 After Phase 2b ECLIPSE Missed Primary Endpoint May 16, 2016 11:35AM


Mar 24, 2016 11:16AM Roth Remains Positive on Aduro Biotech (ADRO) Upon Start of SEASCAPE Trial; Affirms at 'Buy'
Mar 21, 2016 12:00PM Roth Remains Positive on Aduro Biotech's (ADRO) CRS-207 ECLIPSE Outcome; Reaffirms at 'Focus Pick'
Feb 1, 2016 11:38AM Current Valuation on Aduro Biotech (ADRO) Doesn't Appreciate Upcoming Opportunities - Roth Capital
Dec 28, 2015 06:16AM Aduro Biotech (ADRO) Added to Focus List at Roth Capital
Nov 24, 2015 12:12PM Streetinsider.com's Hot Lunchtime Reads 11/24: (ADRO) (IMPV) (AAPL) (LLL)
Nov 24, 2015 10:53AM Aduro Biotech (ADRO) Adverse Event was Protocol Violation, Roth Capital Says; Sees Sell-Off as Overreaction
Nov 24, 2015 10:19AM Roth Trims PT on Aduro BioTech (ADRO) to $68; Notes Several Catalysts for FY16
Sep 9, 2015 10:54AM Roth Capital Reiterates Buy on Aduro Biotech (ADRO) Following Announced Incyte (INCY) Collaboration
Aug 25, 2015 09:28AM Roth Capital Highlights Biotech Picks 'for the Turn' and Over the Long Haul (PTN) (LGND) (TGTX) (CLDX)
May 14, 2015 07:19AM Roth Capital Reiterated Bullish Stance on Aduro Biotech (ADRO) Following ASCO Abstracts
Apr 20, 2015 11:14AM Roth Affirms Aduro Biotech (ADRO) at 'Buy'; Novartis' (NVS) Data Validates Mesothelin CAR-T
Apr 20, 2015 09:28AM Pre-Open Stock Movers 4/20: (HQCL) (ADRO) (HAS) Higher; (AMPE) (FARO) (RCL) Lower (more...)
Apr 20, 2015 09:27AM UPDATE: Roth Capital Starts ADURO BIOTECH (ADRO) at Buy, PT $74